Trinity Biotech (TRIB) Gross Margin (2009 - 2024)
Trinity Biotech recorded quarterly Gross Margin of 30.76% in Q4 2024, down 12.2% quarter-over-quarter from 35.03% in Q3 2024, and down 325.0% year-over-year from 13.67% in Q1 2024.
Trinity Biotech's Gross Margin history runs 16 years deep, the most recent figure standing at 30.76% for Q4 2024.
- In Q4 2024, Gross Margin fell 325.0% year-over-year to 30.76%; the TTM figure through Dec 2024 stood at 34.83% (up 61.0% YoY), while the FY2025 annual figure was 38.57%, up 374.0% from the prior year.
- Gross Margin came in at 30.76% for Q4 2024 at Trinity Biotech, down from 35.03% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 52.4% in Q3 2020 to a low of 2.1% in Q3 2022.
- A 5-year average of 36.84% and a median of 37.31% in 2021 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 3835 bps in 2022 and surged 2707 bps in 2023, its largest moves.
- Trinity Biotech's Gross Margin stood at 47.79% in 2020, then dropped by 22 bps to 37.08% in 2021, then decreased by 8 bps to 34.18% in 2022, then decreased by 0 bps to 34.01% in 2023, then fell by 10 bps to 30.76% in 2024.
- According to Business Quant data, Gross Margin over the past three periods registered 30.76%, 35.03%, and 36.19% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.76% |
| Sep 30, 2024 | 35.03% |
| Jun 30, 2024 | 36.19% |
| Mar 31, 2024 | 37.55% |
| Dec 31, 2023 | 34.01% |
| Sep 30, 2023 | 29.16% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | 37.58% |
| Dec 31, 2022 | 34.18% |
| Sep 30, 2022 | 2.10% |
| Jun 30, 2022 | 36.20% |
| Mar 31, 2022 | 38.16% |
| Dec 31, 2021 | 37.08% |
| Sep 30, 2021 | 40.45% |
| Jun 30, 2021 | 42.67% |
| Mar 31, 2021 | 42.64% |
| Dec 31, 2020 | 47.79% |
| Sep 30, 2020 | 52.40% |
| Jun 30, 2020 | 42.88% |
| Mar 31, 2020 | 43.80% |
| Dec 31, 2019 | 43.50% |
| Sep 30, 2019 | 40.95% |
| Jun 30, 2019 | 41.95% |
| Mar 31, 2019 | 42.40% |
| Dec 31, 2018 | 41.73% |
| Sep 30, 2018 | 42.09% |
| Jun 30, 2018 | 43.23% |
| Mar 31, 2018 | 43.82% |
| Dec 31, 2017 | 41.47% |
| Sep 30, 2017 | 42.95% |
| Jun 30, 2017 | 42.51% |
| Mar 31, 2017 | 42.02% |
| Dec 31, 2016 | 40.03% |
| Sep 30, 2016 | 44.65% |
| Jun 30, 2016 | 44.95% |
| Mar 31, 2016 | 43.08% |
| Dec 31, 2015 | 43.18% |
| Sep 30, 2015 | 46.52% |
| Jun 30, 2015 | 46.97% |
| Mar 31, 2015 | 47.94% |
| Dec 31, 2014 | 47.47% |
| Sep 30, 2014 | 47.90% |
| Jun 30, 2014 | 48.10% |
| Mar 31, 2014 | 48.60% |
| Dec 31, 2013 | 49.61% |
| Sep 30, 2013 | 49.66% |
| Jun 30, 2013 | 49.02% |
| Mar 31, 2013 | 50.01% |
| Dec 31, 2012 | 50.59% |
| Sep 30, 2012 | 51.02% |
| Jun 30, 2012 | 51.60% |
| Mar 31, 2012 | 51.65% |
| Dec 31, 2011 | 51.53% |
| Sep 30, 2011 | 51.73% |
| Jun 30, 2011 | 51.42% |
| Mar 31, 2011 | 51.23% |
| Dec 31, 2010 | 50.77% |
| Sep 30, 2010 | 50.60% |
| Jun 30, 2010 | 49.31% |
| Mar 31, 2010 | 46.63% |
| Dec 31, 2009 | 44.46% |
| Sep 30, 2009 | 45.01% |